Equities research analysts expect that Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) will post sales of $250,000.00 for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Crinetics Pharmaceuticals’ earnings. The highest sales estimate is $550,000.00 and the lowest is $100,000.00. The firm is scheduled to announce its next earnings report on Wednesday, […]